Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Humanised monoclonal antibody against myostatin

EU orphan designation number: EU/3/13/1105   
Active ingredient: Humanised monoclonal antibody against myostatin
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Pfizer Europe MA EEIG
Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2013 Orphan designation EMA/OD/164/12 (2013)806 of 8/02/2013
21/11/2018 Transfer of orphan designation EMA/OD/164/12/T/01 (2018)7835 of 19/11/2018